Sartorius publicizes the launch of the CellCelector CLD, an automatic imaging and cell isolation platform designed to simplify and speed up monoclonal cell line growth (CLD). Combining high-speed scanning, superior imaging, and mild clone retrieval, it allows scientists to quickly establish, confirm, and isolate probably the most promising clones, whereas sustaining viability and guaranteeing dependable documentation.
What used to take months can now be accomplished in roughly seven weeks. The CellCelector CLD offers groups the arrogance to maneuver from screening to steady, high-producing cell traces sooner than normal workflows, with full traceability at each step.”
Darius Wilson, Product Supervisor of CellCelector Techniques, Sartorius
The CellCelector CLD delivers high-speed automated scanning to detect monoclonal wells and observe clonal progress over time. Function-built imaging ensures constant, high-quality outcomes even for probably the most difficult targets, supporting assured screening throughout giant candidate swimming pools. Paired with Sartorius’ Subsequent Technology CLD Nanowell Plates, the equal of 885 normal 96‑nicely plates, the platform screens giant candidate swimming pools and delivers 40 % extra monoclonal wells and over threefold increased clone outgrowth than normal Nanowell Plates. It yields as much as 15,000 monoclonality‑verified clones able to decide in simply 4 days.
As soon as prime clones are recognized, the system helps mild isolation with as much as one hundred pc switch effectivity and viability, defending precious cell traces for downstream enlargement. The built-in EMA 410- compliant productiveness assay ensures each choice choice is traceable, giving analysis groups the regulatory confidence they want from day one.
The CellCelector CLD is a part of Sartorius’ broader cell line growth ecosystem, bringing collectively devices, consumables, reagents, and media right into a single, cohesive workflow. For bioprocess groups underneath strain to maneuver sooner, cut back prices, and meet regulatory requirements, it represents a significant step ahead within the capabilities of automated CLD .